DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients

201526 citationsJournal Articlegreen Open Access

Authors

Oswaldo Lorenzo‐Betancor · Mayo Clinic in Florida

Kotaro Ogaki · Jacksonville College

Alexandra I. Soto‐Ortolaza · Mayo Clinic in Florida

Catherine Labbé · Mayo Clinic in Florida

Ronald L. Walton · Jacksonville College

Audrey Strongosky · Jacksonville College

Jay A. van Gerpen

Abstract

Our results indicate that the region surrounding the DNAJC13 p.Asn855Ser substitution is highly conserved and mutations in this exon are not a common cause of PD or LBD among Caucasian populations.

Topics & Keywords

Neurological diseases and metabolism RNA regulation and disease Parkinson's Disease Mechanisms and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Neurology

Volume 22, Issue 9, pp. 1323-1325

DOI: 10.1111/ene.12770

Field-Weighted Citation Impact: 2.42